Correlation Between Mereo BioPharma and Surgical Science

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Surgical Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Surgical Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and Surgical Science Sweden, you can compare the effects of market volatilities on Mereo BioPharma and Surgical Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Surgical Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Surgical Science.

Diversification Opportunities for Mereo BioPharma and Surgical Science

-0.65

Correlation Coefficient

Mereo BioPharma  Surgical Science

Excellent diversification

The 3 months correlation between Mereo and Surgical is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Surgical Science Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surgical Science Sweden and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Surgical Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surgical Science Sweden has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Surgical Science go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Surgical Science

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to under-perform the Surgical Science. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.13 times less risky than Surgical Science. The stock trades about -0.17 of its potential returns per unit of risk. The Surgical Science Sweden is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  18,240  in Surgical Science Sweden on December 1, 2024 and sell it today you would lose (2,490) from holding Surgical Science Sweden or give up 13.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Mereo BioPharma Group  vs.  Surgical Science Sweden

Mereo BioPharma Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Surgical Science Sweden

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Surgical Science may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Mereo BioPharma and Surgical Science

The main advantage of trading using opposite Mereo BioPharma and Surgical Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Surgical Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgical Science will offset losses from the drop in Surgical Science's long position.

The idea behind Mereo BioPharma Group and Surgical Science Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.